Transforming Behavioral Health Care with Innovative Technologies

Linda Dimeff, Ph.D., Kelly Koerner, Ph.D.

Introduction

Linda Dimeff, Ph.D. is President and Chief Scienfitic Officer at Evidence-Based Practice Institute, Inc., Institute Director at Portland DBT institute, and Clinical Faculty in the Department of Psychology at the University of Washington.  Directly mentored and supervised by Marsha M. Linehan, Ph.D. and G. Alan Marlatt, Ph.D. throughout her graduate training, Dr. Dimeff has focused her career in developing, testing, and disseminating evidence-based treatments for multi-problem, complex, difficult-to-treat suicidal persons with borderline personality disorder and substance use disorders, and to the innovative applications of technology to further the dissemination process.  She is the recipient of over 20 NIH-funded grants and has published over 50 peer-reviewed articles and two books, including DBT in Clinical Practice.  Dr. Dimeff has trained and supervised clinicians and front line staff in diverse settings throughout the world in DBT and other EBPs. 

Kelly Koerner, Ph.D. serves as CEO and Creative Director of the Evidence-Based Practice Institute, a social enterprise that helps practitioners learn and use evidence-based mental health care practices.  Science values, design skills and social entrepreneurship meld as she develops highly collaborative, technology-based tools to disseminate evidence-based practices (EBPs).  Her experience includes extensive practical experience in supporting individuals and systems as they learn, implement, and sustain EBPs in diverse settings and educational backgrounds (e.g., from paraprofessionals in juvenile justice facilities to masters-level counselors in community mental health and substance abuse treatment centers to research therapists in academic clinical trials).  She maintains an active research program and is Clinicl Faculty at the University of Washington and author of Doing DBT: A Practical Guide.

Learning Objectives

1. List two problems commonly associted with the "Training as Usual" approach.

2. Describe the main clinical outcome findings in the field of computerized cognitive-behavioral therapy.

3. List three benefits of leveraging innovative technologies to improve the delivery of behavioral healthcare.

Live webcast available at: http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live. Ethos will be implemented for all post presentation surveys. To document your attendance, please text the code given at the presentation to 507-200-3010. For questions, email rstpsychgr@mayo.edu.

Accreditation Statement

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s)

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

APA
The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.

Archived webcast available at: Psychiatry & Psychology Video Library

Industry Acknowledgment (if applicable): None.

All participants MUST complete the evaluation in order to get CME or APA Credit.

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
 

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Mark Frye, M.D. - Mayo Clinic

Grant Support: AssureRx, Janssen R&D, Myriad, Pfizer Consultant: Janssen R&D, Mitsubishi Tanabe Pharma Corp., Myriad Genetics, Sunovion, Supernus Pharmaceuticals, Teva Pharmaceuticals, Neuralstem, Inc.

CME/Travel: American Physician Institute, CME Outfitters

Speakers Linda Dimeff, Ph.D. and Kelly Koerner, Ph.D.:  50-50 ownership in Evidence-Based Practice Institute.

No relevant financial relationship(s) with industry:
Kriti Gandhi, M.D., Allison Holgerson, Ph.D., Matej Markota, M.D., Charlene Nelson, Reem Shafi, M.B.B.S., Larua Suarez, M.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:

NONE